flurbiprofen has been researched along with Cardiometabolic Syndrome in 1 studies
Flurbiprofen: An anti-inflammatory analgesic and antipyretic of the phenylalkynoic acid series. It has been shown to reduce bone resorption in periodontal disease by inhibiting CARBONIC ANHYDRASE.
flurbiprofen : A monocarboxylic acid that is a 2-fluoro-[1,1'-biphenyl-4-yl] moiety linked to C-2 of propionic acid. A non-steroidal anti-inflammatory, analgesic and antipyretic, it is used as a pre-operative anti-miotic as well as orally for arthritis or dental pain.
Cardiometabolic Syndrome: A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components not only include metabolic dysfunctions of METABOLIC SYNDROME but also HYPERTENSION, and ABDOMINAL OBESITY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Obesity is one of the major risk factors of metabolic syndrome, such as hypertension, hyperlipidemia, and diabetes." | 2.53 | The Mechanisms and Pharmacological Strategy for Treatment of ER Stress-induced Metabolic Syndrome. ( Hosoi, T; Ozawa, K, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hosoi, T | 1 |
| Ozawa, K | 1 |
1 review available for flurbiprofen and Cardiometabolic Syndrome
| Article | Year |
|---|---|
The Mechanisms and Pharmacological Strategy for Treatment of ER Stress-induced Metabolic Syndrome.
Topics: Drug Discovery; Endoplasmic Reticulum Stress; Flurbiprofen; Humans; Hypothalamus; Leptin; Metabolic | 2016 |